CIRM Funded Clinical Trials

A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus

Disease Area:
Lupus, Systemic Lupus Erythematosus (SLE)
CIRM Grant:
CLIN2-16303 (Pre-Active)
Award Value:
Trial Sponsor:
Fate Therapeutics, Inc.
Trial Stage:
Phase 1
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website